1318792-78-7

Basic information

• Product Name: 3-amino-6-(4-(3-hydroxypropyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide
• Synonyms: 3-amino-6-(4-(3-hydroxypropyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide
• CAS NO: 1318792-78-7
• Molecular Weight: 349.392
• Mol File: 1318792-78-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-amino-6-(4-(3-hydroxypropyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-amino-6-(4-(3-hydroxypropyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide(1318792-78-7)
• EPA Substance Registry System: 3-amino-6-(4-(3-hydroxypropyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide(1318792-78-7)

Safety Data

• Hazardous Substances Data: 1318792-78-7(Hazardous Substances Data)

Upstream product

• 1318792-77-6 3-amino-6-(4-(3-(tert-butyldimethylsilyloxy)propyl)phenyl)-N-(pyridin-3-yl)-pyrazine-2-carboxamide 
• 16298-03-6 Methyl 3-amino-2-pyrazinecarboxylate 
• 936023-12-0 2-{4-[3-(tert-butyl-dimethyl-silanyloxy)-propyl]-phenyl}-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 486424-37-7 3-amino-6-bromo-pyrazine-2-carboxylic acid 
• 486422-03-1 3-amino-6-bromo-N-pyridin-3-ylpyrazine-2-carboxamide 
• 6966-01-4 methyl 3-amino-6-bromopyrazine-2-carboxylate 
• 1643-30-7 3-(4-bromophenyl)propionic acid 
• 153993-80-7 [3-(4-bromophenyl)propoxy](tert-butyl)dimethylsilane 
• 25574-11-2 3-(4-bromophenyl)propanol 

Downstream Products

• 1318792-79-8 3-(4-(5-amino-6-(pyridin-3-ylcarbamoyl)pyrazin-2-yl)phenyl)propyl methanesulfonate 
• 1318792-63-0 AZD₇₉₂₉ 
• 1318792-64-1 3-amino-6-(4-{3-[(3-methoxypropyl)amino]propyl}phenyl)-N-pyridin-3-ylpyrazine-2-carboxamide mono-besylate 
• 1318792-65-2 3-amino-6-(4-{3-[(3-methoxypropyl)amino]propyl}phenyl)-N-pyridin-3-ylpyrazine-2-carboxamide mono-tosylate 
• 1318792-68-5 3-amino-6-(4-{3-[(3-methoxypropyl)amino]propyl}phenyl)-N-pyridin-3-ylpyrazine-2-carboxamide mono-DL-mandelate 

Relevant articles and documents

PYRAZINE DERIVATIVES

The invention concerns pyrazine derivatives of the Formula (I) or pharmaceutically-acceptable salts thereof; wherein each of n, m and R has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of bone-related disorders or conditions